Table I.
Preoperative transfusion
|
|||
---|---|---|---|
Characteristic, % | No (n = 58,712), 96.6% |
Yes (n = 2,073), 3.4% |
X2 P value |
Female | 53 | 49 | .002 |
Age, y | <.001 | ||
<65 | 55 | 34 | |
65–79 | 33 | 39 | |
80+ | 12 | 27 | |
Body mass index | <.001 | ||
<18.5 | 3.2 | 5.3 | |
18.5–24.9 | 31 | 35 | |
25–29.9 | 33 | 30 | |
30–34.9 | 20 | 16 | |
35+ | 14 | 13 | |
ASA class 3 or 4 | 55 | 86 | <.001 |
Emergency case | 15 | 40 | <.001 |
Indication | <.001 | ||
Cancer | 38 | 41 | |
Diverticulitis | 23 | 9.8 | |
Polyp | 8.6 | 1.0 | |
Inflammatory bowel disease | 8.0 | 7.6 | |
Bleeding | 0.5 | 18 | |
Volvulus | 2.8 | 1.3 | |
Other | 20 | 21 | |
Operative approach | <.001 | ||
Open | 40 | 65 | |
Minimally invasive | 52 | 29 | |
Converted | 7.9 | 6.5 | |
Sepsis | 6.1 | 11 | <.001 |
Septic shock | 1.8 | 8.0 | <.001 |
Hematocrit | <.001 | ||
≥36 | 67 | 6.3 | |
30–35.9 | 24 | 31 | |
24–29.9 | 8.8 | 46 | |
<24 | 0.8 | 16 | |
Chemotherapy within 90 d | 5.5 | 4.9 | .375 |
Diabetes | 15 | 22 | <.001 |
Current smoker | 17 | 14 | <.001 |
Dyspnea | 6.9 | 14 | <.001 |
Dependent functional status | 3.3 | 9.4 | <.001 |
Ventilator-dependent | 0.8 | 6.6 | <.001 |
COPD | 5.5 | 10 | <.001 |
Ascites | 1.0 | 4.0 | <.001 |
Congestive heart failure | 1.0 | 5.4 | <.001 |
Hypertension | 49 | 63 | <.001 |
Acute renal failure | 0.6 | 3.5 | <.001 |
Dialysis-dependent | 1.0 | 5.5 | <.001 |
Disseminated cancer | 6.4 | 11 | <.001 |
Open wound/wound infection | 2.0 | 6.5 | <.001 |
Steroid use | 9.5 | 14 | <.001 |
>10% weight loss in past 6 mo | 5.0 | 11 | <.001 |
Coagulopathy | 4.6 | 19 | <.001 |
Intra/postoperative transfusion | 11 | 48 | <.001 |
Operative time, min | <.001 | ||
<60 | 3.9 | 5.5 | |
60–119 | 26 | 33 | |
120–179 | 32 | 33 | |
180+ | 38 | 29 |
COPD, Chronic obstructive pulmonary disease.
Missing data: approach (n = 50, 0.1%), body mass index (n = 1,100, 1.8%), functional status (n = 273, 0.4%), operative time (n = 16, <0.1%).